GlassScriptPhysician profile
Mithun Chakravarthy
NPI 1053606707
$21,368.01
in general payments reported to CMS, 2019-2025
41 companies · $1,964 in 2025
The $1,964 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,482 · 2020: $861 · 2021: $3,403 · 2022: $2,662 · 2023: $1,769 · 2024: $4,228 · 2025: $1,964.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,881 · Travel and Lodging: $1,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,880.63 |
| Travel and Lodging | $1,079.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,597.30 | 2019-2025 | Mitraclip, Triclip, Coroflow |
| Abiomed | $4,698.84 | 2019-2025 | Impella |
| Inari Medical, INC. | $1,052.28 | 2020-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Edwards Lifesciences Corporation | $1,024.91 | 2021-2024 | Evoque |
| Medtronic, INC. | $977.45 | 2021-2024 | Corevalve Evolut R |
| Boston Scientific Corporation | $924.63 | 2019-2025 | Rotapro, Filterwire Ez, Mamba |
| Ancora Heart, INC. | $804.12 | 2021 | |
| Amgen INC. | $664.97 | 2020-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $534.84 | 2022-2025 | |
| Cardiovascular Systems INC. | $473.74 | 2019-2023 | Diamondback Coronary |
| Shockwave Medical, INC | $467.63 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $454.21 | 2020-2025 | Lokelma, Farxiga |
| Janssen Pharmaceuticals, INC | $445.97 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $437.94 | 2019-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $374.44 | 2021-2025 | Jardiance |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $303.88 | 2019-2025 | Camzyos, Eliquis |
| Novo Nordisk INC | $289.86 | 2024-2025 | Wegovy, Ozempic |
| Heartflow, INC. | $248.46 | 2023-2025 | Ffrct |
| Pfizer INC. | $242.60 | 2019-2025 | |
| Medtronic Vascular, INC. | $217.05 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $185.32 | 2023-2025 | Optimizer, Optimizer |
| Cardiac Dimensions, INC. | $171.64 | 2024 | |
| Cvrx, INC. | $155.57 | 2021-2024 | Barostim Neo System |
| Angiodynamics, INC. | $133.64 | 2020-2025 | Alphavac, Angiovac |
| Philips North America LLC | $92.15 | 2019-2021 | |
| Altathera Pharmaceuticals LLC | $70.82 | 2022-2023 | Sotalol Hydrochloride |
| Bayer Healthcare Pharmaceuticals INC. | $52.16 | 2025 | |
| Terumo Medical Corporation | $33.95 | 2023 | Tr Band, Glidewire, Heartrail |
| Trisalus Life Sciences, INC. | $27.10 | 2025 | Trinav Infusion System |
| Esperion Therapeutics, INC. | $26.06 | 2021 | |
| Cook Medical LLC | $24.94 | 2020 | |
| W. L. Gore & Associates, INC. | $23.81 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $22.75 | 2025 | Uptravi, Opsynvi |
| Teleflex LLC | $21.66 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $21.35 | 2023 | Arcalyst |
| Tactile Systems Technology INC | $20.56 | 2023 | Flexitouch Plus, Entre Plus |
| Regeneron Healthcare Solutions, INC. | $20.50 | 2025 | Evkeeza |
| Getinge USA Sales, LLC | $14.67 | 2025 | Cardiosave Rescue |
| Bard Peripheral Vascular, INC. | $14.24 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mithun Chakravarthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.